China Announces Trade Concessions as Liu He Heads to U.S.
(Bloomberg) -- Go inside the global economy with Stephanie Flanders in her new podcast, Stephanomics. Sign up here.
The Chinese government said it will extend a suspension of retaliatory tariffs on U.S. autos and include the opioid fentanyl in a list of controlled substances, two steps that could generate a positive atmosphere for trade negotiations due to resume this week.
Beijing temporarily scrapped the 25 percent tariff imposed on vehicles as a tit-for-tat measure on Jan. 1, after the White House delayed a rise in tariffs on $200 billion of products that had been due that day. The Ministry of Finance announced an extension of the suspension on Sunday, without giving a specific end date.
Vice Premier Liu He, China's trade envoy, left for the U.S. on Monday, according to the Ministry of Foreign Affairs.
Chinese officials also pledged to tighten regulation on fentanyl from next month, a promise President Xi Jinping already made to President Donald Trump at a December meeting in Argentina. The inclusion of the drug as a controlled substance in a category of non-medicinal narcotic drugs and psychotropic substances will start May 1, according to the China National Narcotics Control Commission.
The moves signal China is trying to keep momentum in trade talks going as they enter what could be the final stretch before Trump and Xi are presented with a text to finalize or sign. Beijing is determined to prevent an escalation of the frictions that have hurt its economy and roiled markets, even as enforcement measures remain a sticking point in negotiations.
China, U.S. Said to Pore Over Details of Text to End Trade War
“What matters is not whether these are big concessions or not, but that they are a quick response to the U.S. concerns," said Gai Xinzhe, a senior analyst at Sino Ocean Capital in Beijing. “It's not like in the past when issues raised in bilateral dialogues dragged on without solution. This is good for enhancing mutual trust in the negotiations.”
‘New Progress'
China touted “new progress” in talks after U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin visited Beijing last week. Both sides have been working line-by-line through the text of an agreement that can be put before Trump and Xi, people familiar said earlier.
The continued suspension of auto tariffs seeks to “create a good atmosphere for China-U.S. economic and trade talks” and is a “positive response” to the U.S. decision to delay import tax increases, the Ministry of Finance said in a statement.
The world's second largest economy saw some early signs of stabilization in March as its manufacturing gauges signaled expansion. But Premier Li Keqiang stressed last week that new threats are arising from weakness in global demand and warned that short-term fluctuations in growth numbers are unavoidable.
Read More: China's Li Sees Sound Economy at Home, Risk of Downturn Abroad
In addition to putting fentanyl on the controlled substance list, China said it will crack down on underground networks who sell the drug online and ship them to the U.S by disrupting their cyber communication channels and stepping up checks on private packages at its customs borders. The synthetic opioid is sold by online distributors across China and is blamed for thousands of overdose deaths in the U.S.
A Look at China's Drug Bazaar Amid Pledge to Fight Fentanyl: Map
Chinese officials also emphasized that the U.S. opioid crisis is largely self-created and cannot be blamed on supply from China.
China “exercised great restraint and did its very best” with the recent moves, compared with the U.S. only mulling to suspend some of its tariffs, said Li Yong, a senior fellow at the China Association of International Trade in Beijing. “Blame does not help to solve the problem. The right attitude should be to enhance cooperation and have construction communication.”
--With assistance from Jing Jin, Rachel Chang, Tian Ying and Yan Zhang.
To contact Bloomberg News staff for this story: Miao Han in Beijing at mhan22@bloomberg.net
To contact the editors responsible for this story: John Liu at jliu42@bloomberg.net, Sharon Chen, Jeffrey Black
©2019 Bloomberg L.P.
With assistance from Bloomberg
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.